Sun Pharma unit poised to buy Canadian biotech Antibe
Sun Pharma's Taro unit has made a bid to acquire Canadian biotech Antibe, a developer of drugs for pain and inflammation.
High-dose semaglutide ramps up weight loss, says Novo
Novo Nordisk's high-dose version of semaglutide boosts its weight-loss ability, but it still can't match its main rival in the obesity market.
AZ, Daiichi get FDA nod for Dato-DXd in breast cancer
AstraZeneca and Daiichi Sankyo have claimed FDA approval for a second antibody-drug conjugate for breast cancer - TROP2-directed Datroway.
Amgen picks up key colorectal cancer okay for KRAS drug
Can a new FDA approval in colorectal cancer kickstart sales growth for Amgen's KRAS inhibitor Lumakras?
Sage sues Biogen after unsolicited takeover bid
Sage Therapeutics has left its view of Biogen's recent takeover bid in little doubt – it has just filed a lawsuit seeking to block the deal.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
4th ADC Analytical Development Summit
The 4th ADC Analytical Development Summit focuses on refining analytical techniques to meet the increasing regulatory demands and product complex
2nd EHS for Biopharma Summit East
As the biopharma industry evolves with rapid advancements in drug development, manufacturing, and research, EHS leaders are tasked with safeguarding employee health, maintaining a culture o
Register Now for the AAPS National Biotechnology Conference
The AAPS National Biotechnology Conference uncovers the trends driving today’s biotech markets.
hubXchange returns with its latest series of roundtables!
hubXchange invites you to participate in its highly-anticipated San Diego Series 2025, a series of focused, high-level roundtable events designed to address key challenges and innovations across th
Advance Best-In-Class Treatment Across CNS, Emergency Use Tr...
With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics.